imipramine has been researched along with melatonin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (34.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Arce, MP; Conde, S; del Barrio, L; Egea, J; García, AG; González-Muñoz, GC; León, R; López, B; López, MG; Martín-de-Saavedra, MD; Pérez, C; Rodríguez-Franco, MI; Romero, A; Villarroya, M | 1 |
| Colau, D; Dolusić, E; Frédérick, R; Larrieu, P; Masereel, B; Moineaux, L; Pilotte, L; Pochet, L; Stroobant, V; Van den Eynde, B; Wouters, J | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Arce, MP; Conde, S; Egea, J; Gil, C; León, R; López, MG; Monjas, L; Pérez, C; Rodríguez-Franco, MI; Villarroya, M | 1 |
| Halbreich, U; Stewart, JW | 1 |
| Ardisson, JL; Belugou, JL; Candito, M; Darcourt, G; Krebs, B; Pringuey, D; Salvati, E; Souêtre, E | 1 |
| Arushanian, EB; Baturin, VA; Ovanesov, KB | 1 |
| Ask, AL; Fowler, CJ; Hall, H; Kelder, D; Ross, SB; Sääf, J | 1 |
| Jarrett, DB; Kupfer, DJ; Miewald, JM | 1 |
| Hariharasubramanian, N; Isaac, I; Nair, NP; Pilapil, C; Quirion, R | 1 |
| Anton-Tay, F; Axelrod, J; Wurtman, RJ | 1 |
| Cooper, TB; Friedman, E; Yocca, FD | 1 |
| Richardson, G; Tate, B | 1 |
| Ekstrom, RD; Golden, RN; Lydiard, RB; Mason, GA; Miller, HL | 1 |
| Abdel-Salam, OM; Arbid, MS; Baiuomy, AR | 1 |
| Bertaina-Anglade, V; Boyer, PA; la Rochelle, CD; Mocaër, E | 1 |
| Ergün, Y; Karaaslan, MF; Orhan, FO | 1 |
| Caumo, W; Detanico, BC; Elisabetsky, E; Freitas, JJ; Hidalgo, MP; Lhullier, FL; Piato, AL | 1 |
1 review(s) available for imipramine and melatonin
| Article | Year |
|---|---|
Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies.
Topics: Antidepressive Agents, Tricyclic; Antimanic Agents; Antioxidants; Circadian Rhythm; Clorgyline; Hormones; Humans; Hypothalamus; Imipramine; Lithium; Melatonin; Monoamine Oxidase Inhibitors | 2000 |
2 trial(s) available for imipramine and melatonin
| Article | Year |
|---|---|
Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication.
Topics: Adolescent; Adult; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Melatonin; Mianserin; Middle Aged; Phenelzine; Random Allocation | 1989 |
Noradrenergic function and clinical outcome in antidepressant pharmacotherapy.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depression; Fluvoxamine; Humans; Imipramine; Melatonin; Norepinephrine; Pineal Gland; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
20 other study(ies) available for imipramine and melatonin
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Agents; Butyrylcholinesterase; Calcium; Cell Death; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Okadaic Acid; Peptide Fragments; Phenothiazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Immunologic Factors; Indoles; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Tryptophan Oxygenase | 2011 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia.
Topics: Alzheimer Disease; Animals; Brain Ischemia; Calcium Channel Blockers; Cholinesterase Inhibitors; Donepezil; Glutamates; Hippocampus; Humans; Indans; Neuroprotective Agents; Piperidines; Rats; Solid-Phase Synthesis Techniques | 2017 |
Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality.
Topics: Adult; Amitriptyline; Body Temperature Regulation; Circadian Rhythm; Depressive Disorder; Female; Humans; Hydrocortisone; Imipramine; Lithium; Male; Melatonin; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Sleep Stages; Thyrotropin; Wakefulness | 1989 |
[Characteristics of the combined action of melatonin and imizin on the structure of forced swimming and the circadian rhythm].
Topics: Animals; Circadian Rhythm; Drug Interactions; Female; Imipramine; Male; Melatonin; Mice; Motor Activity; Physical Exertion; Swimming | 1989 |
Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine.
Topics: Alanine; Animals; Antidepressive Agents; Body Weight; Cerebral Cortex; Circadian Rhythm; Dihydroalprenolol; Hypothalamus; Imipramine; Kinetics; Male; Melatonin; Norepinephrine; Phenethylamines; Pineal Gland; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Zimeldine | 1986 |
Acute changes in sleep-related hormone secretion of depressed patients following oral imipramine.
Topics: Administration, Oral; Adult; Depressive Disorder; Drug Administration Schedule; Electroencephalography; Evoked Potentials; Female; Growth Hormone; Hormones; Humans; Hydrocortisone; Imipramine; Male; Melatonin; Middle Aged; Prolactin; Sleep Stages | 1988 |
Effect of imipramine on the circadian rhythm of plasma melatonin in unipolar depression.
Topics: Adult; Aged; Circadian Rhythm; Depressive Disorder; Female; Humans; Imipramine; Male; Melatonin; Middle Aged; Norepinephrine | 1986 |
Inhibition of the metabolism of H3-melatonin by phenothiazines.
Topics: Amphetamine; Animals; Antimetabolites; Body Temperature; Brain; Chlorpromazine; Depression, Chemical; Desipramine; Female; Imipramine; Liver; Melatonin; Phenobarbital; Phenothiazines; Promazine; Promethazine; Rats; Tritium | 1968 |
Antidepressant drugs with varying pharmacological profiles alter rat pineal beta adrenergic-mediated function.
Topics: Acetyltransferases; Animals; Antidepressive Agents; Dihydroalprenolol; Imipramine; Iprindole; Male; Melatonin; Phenothiazines; Pineal Gland; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin; Suprachiasmatic Nucleus | 1984 |
Studies on the anti-inflammatory effect of fluoxetine in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Carrageenan; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Edema; Fluoxetine; Foot; Imipramine; Indomethacin; Inflammation; Lactones; Melatonin; Pyrazoles; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Sulfones; Time Factors; Trazodone | 2004 |
Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.
Topics: Acetamides; Aminopyridines; Animals; Antidepressive Agents; Avoidance Learning; Helplessness, Learned; Imipramine; Indoles; Male; Melatonin; Rats; Rats, Wistar; Receptors, Melatonin; Serotonin 5-HT2 Receptor Antagonists; Thiophenes | 2006 |
Combination therapy of imipramine and melatonin: additive antidepressant effect in mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Imipramine; Melatonin; Mice; Mice, Inbred BALB C; Motor Activity; Swimming | 2008 |
Antidepressant-like effects of melatonin in the mouse chronic mild stress model.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Chronic Disease; Circadian Rhythm; Corticosterone; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Imipramine; Male; Melatonin; Mice; Mice, Inbred BALB C; Pituitary-Adrenal System; Stress, Psychological | 2009 |